Skip to content

Author

Fawaz O. Alenazy

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world toxicity and discontinuation risk in ibrutinib therapy: a retrospective cohort study

The temporal findings support continued surveillance throughout therapy but do not establish a phase-specific monitoring strategy, and Ibrutinib was associated with substantial toxicity and frequent treatment modification in routine clinical practice.

Wid M. Alyamani, Attiah Khobrani, Fawaz O. Alenazy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.